Regulation (EU) 2018/1718 amending Regulation (EC) No 726/2004 as regards the location of the seat of the European Medicines Agency

Summary:

On 29 November 2017 the European Commission presented a proposal for a Regulation on the new location of the European Medicines Agency. The European Parliament and the Council of the European Union adopted the Regulation on 14 November 2018.

Further information:

The European Medicines Agency (EMA) was established by Regulation (EEC) No 2309/93, which was replaced by Regulation (EC) No 726/2004. In accordance with this Regulation the European Medicines Agency was located in London, United Kingdom.

In March 2017 the United Kingdom notified to the European Council its intention to leave the Union. In November 2017, the 27 remaining Member States, in the margins of the General Affairs Council (Art. 50), selected Amsterdam, the Netherlands, as the new seat of the European Medicines Agency.

Official

EUR-Lex: COM(2017)735: Proposal for a Regulation amending Regulation (EC) No 726/2004 as regards the location of the seat of the European Medicines Agency https://eur-lex.europa.eu/legal-content/EN/HIS/?uri=COM:2017:735:FIN

---

ESO Records

Legislative amendments for the relocation of the European Medicines Agency and the European Banking Authority https://www.europeansources.info/record/legislative-amendments-for-the-relocation-of-the-european-medicines-agency-and-the-european-banking-authority/

---